Novel Pertussis Vaccines: Challenge Models ‘Promising’ But Need More Work

A US FDA Advisory Committee responded enthusiastically to the potential use of challenge models to enable pivotal trials of novel pertussis vaccines, but most members suggested more refinements are needed before they are ready to use.

A company wants to initiate a pertusis vaccine trial using a human challenge model, but the FDA is unsure of the idea. (Shutterstock)

More from Vaccines

More from R&D